TUMOR HISTOLOGY FOLLOWING INDUCTION CHEMOTHERAPY AND/OR HIGH-DOSE CHEMOTHERAPY AND ITS IMPACT ON THE OUTCOME OF PATIENTS WITH HIGH-RISK NEUROBLASTOMA

被引：0
|
作者：
Hishiki, T. [1 ]
Horie, H. [2 ]
Higashimoto, Y. [1 ]
Yotsumoto, K. [1 ]
Komatsu, S. [1 ]
Okimoto, Y. [3 ]
Kakuda, H. [3 ]
Taneyamai, Y. [3 ]
Yoshida, H. [4 ]
Iwai, J. [1 ]
机构：
[1] Chiba Childrens Hosp, Dept Pediat Surg, Chiba, Japan
[2] Chiba Childrens Hosp, Dept Pathol, Chiba, Japan
[3] Chiba Childrens Hosp, Dept Hematol & Oncol, Chiba, Japan
[4] Chiba Univ, Grad Sch Med, Dept Pediat Surg, Chiba, Japan
来源：
PEDIATRIC BLOOD & CANCER | 2014年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EP-348
引用
收藏
页码：S331 / S331
页数：1
相关论文
共 50 条
  • [31] Predictors of Survival in Patients with High-Risk Neuroblastoma who Failed Tandem High-Dose Chemotherapy and Autologous Stem Cell Transplantation
    Yi, E. S.
    Son, M. H.
    Ma, Y. E.
    Cho, H. W.
    Ju, H. Y.
    Lee, J. W.
    Yoo, K. H.
    Sung, K. W.
    Koo, H. H.
    PEDIATRIC BLOOD & CANCER, 2019, 66 : S345 - S345
  • [32] Tandem high-dose chemotherapy with thiotepa and busulfan–melphalan and autologous stem cell transplantation in very high-risk neuroblastoma patients
    C Pasqualini
    C Dufour
    G Goma
    M-A Raquin
    V Lapierre
    D Valteau-Couanet
    Bone Marrow Transplantation, 2016, 51 : 227 - 231
  • [33] Autologous stem cell transplantation following high-dose chemotherapy in children with high-risk neuroblastoma: Practicality in resource-limited countries
    Lau, Sie Chong Doris
    Unni, Mohamed Najib Mohamed
    Teh, Kok Hoi
    Aziz, Mimi Azura
    Muda, Zulaiha
    Thomas, Shoba Anne
    Quah, Shiao Wei
    Ibrahim, Hishamshah
    Othman, Ida Shahnaz
    PEDIATRIC BLOOD & CANCER, 2020, 67 (05)
  • [34] Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma
    Martin, Alissa
    Schneiderman, Jennifer
    Helenowski, Irene B.
    Morgan, Elaine
    Dilley, Kimberley
    Danner-Koptik, Karina
    Hatahet, Mohamad
    Shimada, Hiroyuki
    Cohn, Susan L.
    Kletzel, Morris
    Hijiya, Nobuko
    PEDIATRIC BLOOD & CANCER, 2014, 61 (08) : 1350 - 1356
  • [35] INADEQUATE RESPONSE TO INDUCTION CHEMOTHERAPY IN CHILDREN WITH HIGH-RISK NEUROBLASTOMA: AN INSTITUTIONAL
    Schrey, D.
    Vaidya, S.
    Levine, D.
    Moreno, L.
    Pearson, A.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 111 - 111
  • [36] Monitoring of disseminated tumor cells in bone marrow in high-risk breast cancer patients treated with high-dose chemotherapy
    Drageset, V
    Nesland, JM
    Erikstein, B
    Skovlund, E
    Sommer, H
    Anker, G
    Wist, E
    Lundgren, S
    Bergh, J
    Kvalheim, G
    INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (11) : 2877 - 2881
  • [37] High-Dose Chemotherapy With Hematopoietic Stem Cell Transplant in Patients With High-Risk Breast Cancer
    Ertz-Archambault, Natalie
    Northfelt, Donald W.
    Sonbol, Mohamad Bassam
    JAMA ONCOLOGY, 2020, 6 (08) : 1299 - 1300
  • [38] Tandem high-dose chemotherapy with thiotepa and busulfan-melphalan and autologous stem cell transplantation in very high-risk neuroblastoma patients
    Pasqualini, C.
    Dufour, C.
    Goma, G.
    Raquin, M-A
    Lapierre, V.
    Valteau-Couanet, D.
    BONE MARROW TRANSPLANTATION, 2016, 51 (02) : 227 - 231
  • [39] High-Dose Chemotherapy with Busulfex and Melphalan As Conditioning Regimen Followed By Autologous STEM CELL Rescue for Pediatric Patients with High-Risk Neuroblastoma
    Bitan, Menachem
    Abu-yaman, Maram
    Cohen-Newman, Nitzan
    Elhasid, Ronit
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2014, 20 (02) : S166 - S166
  • [40] HIGH-DOSE RAPID SCHEDULE CHEMOTHERAPY FOR DISSEMINATED NEUROBLASTOMA
    PEARSON, ADJ
    CRAFT, AW
    PINKERTON, CR
    MELLER, ST
    REID, MM
    EUROPEAN JOURNAL OF CANCER, 1992, 28A (10) : 1654 - 1659
12345